These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37650282)

  • 21. Molecular genetics of meningiomas.
    Ragel BT; Jensen RL
    Neurosurg Focus; 2005 Nov; 19(5):E9. PubMed ID: 16398473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric meningioma: current approaches and future direction.
    Kotecha RS; Junckerstorff RC; Lee S; Cole CH; Gottardo NG
    J Neurooncol; 2011 Aug; 104(1):1-10. PubMed ID: 21203895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
    Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
    Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Meningioma].
    Sasaki H
    No Shinkei Geka; 2023 Sep; 51(5):829-836. PubMed ID: 37743334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel therapies for meningiomas.
    Wen PY; Drappatz J
    Expert Rev Neurother; 2006 Oct; 6(10):1447-64. PubMed ID: 17078786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic/molecular alterations of meningiomas and the signaling pathways targeted.
    Domingues P; González-Tablas M; Otero Á; Pascual D; Ruiz L; Miranda D; Sousa P; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
    Oncotarget; 2015 May; 6(13):10671-88. PubMed ID: 25965831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meningioma: an update.
    Lusis E; Gutmann DH
    Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetics of meningiomas: Building the roadmap towards personalized therapy.
    Peyre M; Kalamarides M
    Neurochirurgie; 2018 Mar; 64(1):22-28. PubMed ID: 25245924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New prospects for management and treatment of inoperable and recurrent skull base meningiomas.
    Johnson MD; Sade B; Milano MT; Lee JH; Toms SA
    J Neurooncol; 2008 Jan; 86(1):109-22. PubMed ID: 17624496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathology and molecular genetics of meningioma: recent advances.
    Shibuya M
    Neurol Med Chir (Tokyo); 2015; 55(1):14-27. PubMed ID: 25744347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.
    Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K
    Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic Landscape of Meningiomas.
    Wang JZ; Nassiri F; Mawrin C; Zadeh G
    Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving concepts in meningioma management in the era of genomics.
    Hsieh AL; Bi WL; Ramesh V; Brastianos PK; Plotkin SR
    Cancer; 2024 Aug; 130(15):2586-2600. PubMed ID: 38753473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STK11 mutation status is associated with decreased survival in meningiomas.
    Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK
    Neurol Sci; 2020 Sep; 41(9):2585-2589. PubMed ID: 32253637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meningiomas and neurofibromatosis for the oncologist.
    Schrell UM; Fahlbusch R; Adams EF
    Curr Opin Oncol; 1994 May; 6(3):247-53. PubMed ID: 8080853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for meningioma: improved gene delivery with targeted adenoviruses.
    Dirven CM; Grill J; Lamfers ML; Van der Valk P; Leonhart AM; Van Beusechem VW; Haisma HJ; Pinedo HM; Curiel DT; Vandertop WP; Gerritsen WR
    J Neurosurg; 2002 Aug; 97(2):441-9. PubMed ID: 12186474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatment of meningiomas.
    McDermott MW
    Curr Opin Neurol; 1996 Dec; 9(6):409-13. PubMed ID: 9007396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonality of multiple meningiomas.
    Stangl AP; Wellenreuther R; Lenartz D; Kraus JA; Menon AG; Schramm J; Wiestler OD; von Deimling A
    J Neurosurg; 1997 May; 86(5):853-8. PubMed ID: 9126902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.